Global Blood Pressure Disorders Drug Market Size, Status and Forecast 2020-2026
SKU ID : QYR-15136550 | Publishing Date : 29-Jan-2020 | No. of pages : 157
Detailed TOC of Global Blood Pressure Disorders Drug Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Blood Pressure Disorders Drug Revenue
1.4 Market Analysis by Type
1.4.1 Global Blood Pressure Disorders Drug Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Diuretics
1.4.3 Angiotensin Converting Enzyme (ACE) Inhibitors
1.4.4 Angiotensin Receptor Blockers (ARBs)
1.4.5 Others
1.5 Market by Application
1.5.1 Global Blood Pressure Disorders Drug Market Share by Application: 2020 VS 2026
1.5.2 Hypertension
1.5.3 Hypotension
1.5.4 Pulmonary Hypertension
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Blood Pressure Disorders Drug Market Perspective (2015-2026)
2.2 Blood Pressure Disorders Drug Growth Trends by Regions
2.2.1 Blood Pressure Disorders Drug Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Blood Pressure Disorders Drug Historic Market Share by Regions (2015-2020)
2.2.3 Blood Pressure Disorders Drug Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Blood Pressure Disorders Drug Market Growth Strategy
2.3.6 Primary Interviews with Key Blood Pressure Disorders Drug Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Blood Pressure Disorders Drug Players by Market Size
3.1.1 Global Top Blood Pressure Disorders Drug Players by Revenue (2015-2020)
3.1.2 Global Blood Pressure Disorders Drug Revenue Market Share by Players (2015-2020)
3.1.3 Global Blood Pressure Disorders Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Blood Pressure Disorders Drug Market Concentration Ratio
3.2.1 Global Blood Pressure Disorders Drug Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Blood Pressure Disorders Drug Revenue in 2019
3.3 Blood Pressure Disorders Drug Key Players Head office and Area Served
3.4 Key Players Blood Pressure Disorders Drug Product Solution and Service
3.5 Date of Enter into Blood Pressure Disorders Drug Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Blood Pressure Disorders Drug Historic Market Size by Type (2015-2020)
4.2 Global Blood Pressure Disorders Drug Forecasted Market Size by Type (2021-2026)
5 Blood Pressure Disorders Drug Breakdown Data by Application (2015-2026)
5.1 Global Blood Pressure Disorders Drug Market Size by Application (2015-2020)
5.2 Global Blood Pressure Disorders Drug Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Blood Pressure Disorders Drug Market Size (2015-2020)
6.2 Blood Pressure Disorders Drug Key Players in North America (2019-2020)
6.3 North America Blood Pressure Disorders Drug Market Size by Type (2015-2020)
6.4 North America Blood Pressure Disorders Drug Market Size by Application (2015-2020)
7 Europe
7.1 Europe Blood Pressure Disorders Drug Market Size (2015-2020)
7.2 Blood Pressure Disorders Drug Key Players in Europe (2019-2020)
7.3 Europe Blood Pressure Disorders Drug Market Size by Type (2015-2020)
7.4 Europe Blood Pressure Disorders Drug Market Size by Application (2015-2020)
8 China
8.1 China Blood Pressure Disorders Drug Market Size (2015-2020)
8.2 Blood Pressure Disorders Drug Key Players in China (2019-2020)
8.3 China Blood Pressure Disorders Drug Market Size by Type (2015-2020)
8.4 China Blood Pressure Disorders Drug Market Size by Application (2015-2020)
9 Japan
9.1 Japan Blood Pressure Disorders Drug Market Size (2015-2020)
9.2 Blood Pressure Disorders Drug Key Players in Japan (2019-2020)
9.3 Japan Blood Pressure Disorders Drug Market Size by Type (2015-2020)
9.4 Japan Blood Pressure Disorders Drug Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Blood Pressure Disorders Drug Market Size (2015-2020)
10.2 Blood Pressure Disorders Drug Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Blood Pressure Disorders Drug Market Size by Type (2015-2020)
10.4 Southeast Asia Blood Pressure Disorders Drug Market Size by Application (2015-2020)
11 India
11.1 India Blood Pressure Disorders Drug Market Size (2015-2020)
11.2 Blood Pressure Disorders Drug Key Players in India (2019-2020)
11.3 India Blood Pressure Disorders Drug Market Size by Type (2015-2020)
11.4 India Blood Pressure Disorders Drug Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Blood Pressure Disorders Drug Market Size (2015-2020)
12.2 Blood Pressure Disorders Drug Key Players in Central & South America (2019-2020)
12.3 Central & South America Blood Pressure Disorders Drug Market Size by Type (2015-2020)
12.4 Central & South America Blood Pressure Disorders Drug Market Size by Application (2015-2020)
13Key Players Profiles
13.1 A1M Pharma AB
13.1.1 A1M Pharma AB Company Details
13.1.2 A1M Pharma AB Business Overview and Its Total Revenue
13.1.3 A1M Pharma AB Blood Pressure Disorders Drug Introduction
13.1.4 A1M Pharma AB Revenue in Blood Pressure Disorders Drug Business (2015-2020))
13.1.5 A1M Pharma AB Recent Development
13.2 Acceleron Pharma Inc
13.2.1 Acceleron Pharma Inc Company Details
13.2.2 Acceleron Pharma Inc Business Overview and Its Total Revenue
13.2.3 Acceleron Pharma Inc Blood Pressure Disorders Drug Introduction
13.2.4 Acceleron Pharma Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
13.2.5 Acceleron Pharma Inc Recent Development
13.3 Ache Laboratorios Farmaceuticos SA
13.3.1 Ache Laboratorios Farmaceuticos SA Company Details
13.3.2 Ache Laboratorios Farmaceuticos SA Business Overview and Its Total Revenue
13.3.3 Ache Laboratorios Farmaceuticos SA Blood Pressure Disorders Drug Introduction
13.3.4 Ache Laboratorios Farmaceuticos SA Revenue in Blood Pressure Disorders Drug Business (2015-2020)
13.3.5 Ache Laboratorios Farmaceuticos SA Recent Development
13.4 Actelion Pharmaceuticals Ltd
13.4.1 Actelion Pharmaceuticals Ltd Company Details
13.4.2 Actelion Pharmaceuticals Ltd Business Overview and Its Total Revenue
13.4.3 Actelion Pharmaceuticals Ltd Blood Pressure Disorders Drug Introduction
13.4.4 Actelion Pharmaceuticals Ltd Revenue in Blood Pressure Disorders Drug Business (2015-2020)
13.4.5 Actelion Pharmaceuticals Ltd Recent Development
13.5 Aerogen Ltd
13.5.1 Aerogen Ltd Company Details
13.5.2 Aerogen Ltd Business Overview and Its Total Revenue
13.5.3 Aerogen Ltd Blood Pressure Disorders Drug Introduction
13.5.4 Aerogen Ltd Revenue in Blood Pressure Disorders Drug Business (2015-2020)
13.5.5 Aerogen Ltd Recent Development
13.6 Anavex Life Sciences Corp
13.6.1 Anavex Life Sciences Corp Company Details
13.6.2 Anavex Life Sciences Corp Business Overview and Its Total Revenue
13.6.3 Anavex Life Sciences Corp Blood Pressure Disorders Drug Introduction
13.6.4 Anavex Life Sciences Corp Revenue in Blood Pressure Disorders Drug Business (2015-2020)
13.6.5 Anavex Life Sciences Corp Recent Development
13.7 AnGes Inc
13.7.1 AnGes Inc Company Details
13.7.2 AnGes Inc Business Overview and Its Total Revenue
13.7.3 AnGes Inc Blood Pressure Disorders Drug Introduction
13.7.4 AnGes Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
13.7.5 AnGes Inc Recent Development
13.8 Arena Pharmaceuticals Inc
13.8.1 Arena Pharmaceuticals Inc Company Details
13.8.2 Arena Pharmaceuticals Inc Business Overview and Its Total Revenue
13.8.3 Arena Pharmaceuticals Inc Blood Pressure Disorders Drug Introduction
13.8.4 Arena Pharmaceuticals Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
13.8.5 Arena Pharmaceuticals Inc Recent Development
13.9 Ascendia Pharmaceuticals LLC
13.9.1 Ascendia Pharmaceuticals LLC Company Details
13.9.2 Ascendia Pharmaceuticals LLC Business Overview and Its Total Revenue
13.9.3 Ascendia Pharmaceuticals LLC Blood Pressure Disorders Drug Introduction
13.9.4 Ascendia Pharmaceuticals LLC Revenue in Blood Pressure Disorders Drug Business (2015-2020)
13.9.5 Ascendia Pharmaceuticals LLC Recent Development
13.10 Ascendis Pharma A/S
13.10.1 Ascendis Pharma A/S Company Details
13.10.2 Ascendis Pharma A/S Business Overview and Its Total Revenue
13.10.3 Ascendis Pharma A/S Blood Pressure Disorders Drug Introduction
13.10.4 Ascendis Pharma A/S Revenue in Blood Pressure Disorders Drug Business (2015-2020)
13.10.5 Ascendis Pharma A/S Recent Development
13.11 AVEO Pharmaceuticals Inc
10.11.1 AVEO Pharmaceuticals Inc Company Details
10.11.2 AVEO Pharmaceuticals Inc Business Overview and Its Total Revenue
10.11.3 AVEO Pharmaceuticals Inc Blood Pressure Disorders Drug Introduction
10.11.4 AVEO Pharmaceuticals Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
10.11.5 AVEO Pharmaceuticals Inc Recent Development
13.12 Bayer AG
10.12.1 Bayer AG Company Details
10.12.2 Bayer AG Business Overview and Its Total Revenue
10.12.3 Bayer AG Blood Pressure Disorders Drug Introduction
10.12.4 Bayer AG Revenue in Blood Pressure Disorders Drug Business (2015-2020)
10.12.5 Bayer AG Recent Development
13.13 Bial - Portela & Ca SA
10.13.1 Bial - Portela & Ca SA Company Details
10.13.2 Bial - Portela & Ca SA Business Overview and Its Total Revenue
10.13.3 Bial - Portela & Ca SA Blood Pressure Disorders Drug Introduction
10.13.4 Bial - Portela & Ca SA Revenue in Blood Pressure Disorders Drug Business (2015-2020)
10.13.5 Bial - Portela & Ca SA Recent Development
13.14 Bioblue Technologies Inc
10.14.1 Bioblue Technologies Inc Company Details
10.14.2 Bioblue Technologies Inc Business Overview and Its Total Revenue
10.14.3 Bioblue Technologies Inc Blood Pressure Disorders Drug Introduction
10.14.4 Bioblue Technologies Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
10.14.5 Bioblue Technologies Inc Recent Development
13.15 Biogen Inc
10.15.1 Biogen Inc Company Details
10.15.2 Biogen Inc Business Overview and Its Total Revenue
10.15.3 Biogen Inc Blood Pressure Disorders Drug Introduction
10.15.4 Biogen Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
10.15.5 Biogen Inc Recent Development
13.16 Biolab Farmaceutica Ltda
10.16.1 Biolab Farmaceutica Ltda Company Details
10.16.2 Biolab Farmaceutica Ltda Business Overview and Its Total Revenue
10.16.3 Biolab Farmaceutica Ltda Blood Pressure Disorders Drug Introduction
10.16.4 Biolab Farmaceutica Ltda Revenue in Blood Pressure Disorders Drug Business (2015-2020)
10.16.5 Biolab Farmaceutica Ltda Recent Development
13.17 BioRestorative Therapies Inc
10.17.1 BioRestorative Therapies Inc Company Details
10.17.2 BioRestorative Therapies Inc Business Overview and Its Total Revenue
10.17.3 BioRestorative Therapies Inc Blood Pressure Disorders Drug Introduction
10.17.4 BioRestorative Therapies Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
10.17.5 BioRestorative Therapies Inc Recent Development
13.18 Boryung Pharmaceutical Co Ltd
10.18.1 Boryung Pharmaceutical Co Ltd Company Details
10.18.2 Boryung Pharmaceutical Co Ltd Business Overview and Its Total Revenue
10.18.3 Boryung Pharmaceutical Co Ltd Blood Pressure Disorders Drug Introduction
10.18.4 Boryung Pharmaceutical Co Ltd Revenue in Blood Pressure Disorders Drug Business (2015-2020)
10.18.5 Boryung Pharmaceutical Co Ltd Recent Development
13.19 Bristol-Myers Squibb Co
10.19.1 Bristol-Myers Squibb Co Company Details
10.19.2 Bristol-Myers Squibb Co Business Overview and Its Total Revenue
10.19.3 Bristol-Myers Squibb Co Blood Pressure Disorders Drug Introduction
10.19.4 Bristol-Myers Squibb Co Revenue in Blood Pressure Disorders Drug Business (2015-2020)
10.19.5 Bristol-Myers Squibb Co Recent Development
13.20 Camurus AB
10.20.1 Camurus AB Company Details
10.20.2 Camurus AB Business Overview and Its Total Revenue
10.20.3 Camurus AB Blood Pressure Disorders Drug Introduction
10.20.4 Camurus AB Revenue in Blood Pressure Disorders Drug Business (2015-2020)
10.20.5 Camurus AB Recent Development
13.21 Capricor Therapeutics Inc
10.21.1 Capricor Therapeutics Inc Company Details
10.21.2 Capricor Therapeutics Inc Business Overview and Its Total Revenue
10.21.3 Capricor Therapeutics Inc Blood Pressure Disorders Drug Introduction
10.21.4 Capricor Therapeutics Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
10.21.5 Capricor Therapeutics Inc Recent Development
13.22 Celsion Corp
10.22.1 Celsion Corp Company Details
10.22.2 Celsion Corp Business Overview and Its Total Revenue
10.22.3 Celsion Corp Blood Pressure Disorders Drug Introduction
10.22.4 Celsion Corp Revenue in Blood Pressure Disorders Drug Business (2015-2020)
10.22.5 Celsion Corp Recent Development
13.23 Celtaxsys Inc
10.23.1 Celtaxsys Inc Company Details
10.23.2 Celtaxsys Inc Business Overview and Its Total Revenue
10.23.3 Celtaxsys Inc Blood Pressure Disorders Drug Introduction
10.23.4 Celtaxsys Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
10.23.5 Celtaxsys Inc Recent Development
13.24 Chiesi Farmaceutici SpA
10.24.1 Chiesi Farmaceutici SpA Company Details
10.24.2 Chiesi Farmaceutici SpA Business Overview and Its Total Revenue
10.24.3 Chiesi Farmaceutici SpA Blood Pressure Disorders Drug Introduction
10.24.4 Chiesi Farmaceutici SpA Revenue in Blood Pressure Disorders Drug Business (2015-2020)
10.24.5 Chiesi Farmaceutici SpA Recent Development
13.25 Chong Kun Dang Pharmaceutical Corp
10.25.1 Chong Kun Dang Pharmaceutical Corp Company Details
10.25.2 Chong Kun Dang Pharmaceutical Corp Business Overview and Its Total Revenue
10.25.3 Chong Kun Dang Pharmaceutical Corp Blood Pressure Disorders Drug Introduction
10.25.4 Chong Kun Dang Pharmaceutical Corp Revenue in Blood Pressure Disorders Drug Business (2015-2020)
10.25.5 Chong Kun Dang Pharmaceutical Corp Recent Development
13.26 Chugai Pharmaceutical Co Ltd
10.26.1 Chugai Pharmaceutical Co Ltd Company Details
10.26.2 Chugai Pharmaceutical Co Ltd Business Overview and Its Total Revenue
10.26.3 Chugai Pharmaceutical Co Ltd Blood Pressure Disorders Drug Introduction
10.26.4 Chugai Pharmaceutical Co Ltd Revenue in Blood Pressure Disorders Drug Business (2015-2020)
10.26.5 Chugai Pharmaceutical Co Ltd Recent Development
13.27 CJ HealthCare Corp
10.27.1 CJ HealthCare Corp Company Details
10.27.2 CJ HealthCare Corp Business Overview and Its Total Revenue
10.27.3 CJ HealthCare Corp Blood Pressure Disorders Drug Introduction
10.27.4 CJ HealthCare Corp Revenue in Blood Pressure Disorders Drug Business (2015-2020)
10.27.5 CJ HealthCare Corp Recent Development
13.28 Complexa Inc
10.28.1 Complexa Inc Company Details
10.28.2 Complexa Inc Business Overview and Its Total Revenue
10.28.3 Complexa Inc Blood Pressure Disorders Drug Introduction
10.28.4 Complexa Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020)
10.28.5 Complexa Inc Recent Development
13.29 Corion Biotech Srl
10.29.1 Corion Biotech Srl Company Details
10.29.2 Corion Biotech Srl Business Overview and Its Total Revenue
10.29.3 Corion Biotech Srl Blood Pressure Disorders Drug Introduction
10.29.4 Corion Biotech Srl Revenue in Blood Pressure Disorders Drug Business (2015-2020)
10.29.5 Corion Biotech Srl Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global Blood Pressure Disorders Drug Market Size, Status and Forecast 2020-2026
List of TablesTable 1. Blood Pressure Disorders Drug Key Market Segments
Table 2. Key Players Covered: Ranking by Blood Pressure Disorders Drug Revenue
Table 3. Ranking of Global Top Blood Pressure Disorders Drug Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Blood Pressure Disorders Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Diuretics
Table 6. Key Players of Angiotensin Converting Enzyme (ACE) Inhibitors
Table 7. Key Players of Angiotensin Receptor Blockers (ARBs)
Table 8. Key Players of Others
Table 9. Global Blood Pressure Disorders Drug Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Blood Pressure Disorders Drug Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Blood Pressure Disorders Drug Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Blood Pressure Disorders Drug Market Share by Regions (2015-2020)
Table 13. Global Blood Pressure Disorders Drug Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Blood Pressure Disorders Drug Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Blood Pressure Disorders Drug Market Growth Strategy
Table 19. Main Points Interviewed from Key Blood Pressure Disorders Drug Players
Table 20. Global Blood Pressure Disorders Drug Revenue by Players (2015-2020) (Million US$)
Table 21. Global Blood Pressure Disorders Drug Market Share by Players (2015-2020)
Table 22. Global Top Blood Pressure Disorders Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blood Pressure Disorders Drug as of 2019)
Table 23. Global Blood Pressure Disorders Drug by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Blood Pressure Disorders Drug Product Solution and Service
Table 26. Date of Enter into Blood Pressure Disorders Drug Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Blood Pressure Disorders Drug Market Size by Type (2015-2020) (Million US$)
Table 29. Global Blood Pressure Disorders Drug Market Size Share by Type (2015-2020)
Table 30. Global Blood Pressure Disorders Drug Revenue Market Share by Type (2021-2026)
Table 31. Global Blood Pressure Disorders Drug Market Size Share by Application (2015-2020)
Table 32. Global Blood Pressure Disorders Drug Market Size by Application (2015-2020) (Million US$)
Table 33. Global Blood Pressure Disorders Drug Market Size Share by Application (2021-2026)
Table 34. North America Key Players Blood Pressure Disorders Drug Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Blood Pressure Disorders Drug Market Share (2019-2020)
Table 36. North America Blood Pressure Disorders Drug Market Size by Type (2015-2020) (Million US$)
Table 37. North America Blood Pressure Disorders Drug Market Share by Type (2015-2020)
Table 38. North America Blood Pressure Disorders Drug Market Size by Application (2015-2020) (Million US$)
Table 39. North America Blood Pressure Disorders Drug Market Share by Application (2015-2020)
Table 40. Europe Key Players Blood Pressure Disorders Drug Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Blood Pressure Disorders Drug Market Share (2019-2020)
Table 42. Europe Blood Pressure Disorders Drug Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Blood Pressure Disorders Drug Market Share by Type (2015-2020)
Table 44. Europe Blood Pressure Disorders Drug Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Blood Pressure Disorders Drug Market Share by Application (2015-2020)
Table 46. China Key Players Blood Pressure Disorders Drug Revenue (2019-2020) (Million US$)
Table 47. China Key Players Blood Pressure Disorders Drug Market Share (2019-2020)
Table 48. China Blood Pressure Disorders Drug Market Size by Type (2015-2020) (Million US$)
Table 49. China Blood Pressure Disorders Drug Market Share by Type (2015-2020)
Table 50. China Blood Pressure Disorders Drug Market Size by Application (2015-2020) (Million US$)
Table 51. China Blood Pressure Disorders Drug Market Share by Application (2015-2020)
Table 52. Japan Key Players Blood Pressure Disorders Drug Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Blood Pressure Disorders Drug Market Share (2019-2020)
Table 54. Japan Blood Pressure Disorders Drug Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Blood Pressure Disorders Drug Market Share by Type (2015-2020)
Table 56. Japan Blood Pressure Disorders Drug Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Blood Pressure Disorders Drug Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Blood Pressure Disorders Drug Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Blood Pressure Disorders Drug Market Share (2019-2020)
Table 60. Southeast Asia Blood Pressure Disorders Drug Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Blood Pressure Disorders Drug Market Share by Type (2015-2020)
Table 62. Southeast Asia Blood Pressure Disorders Drug Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Blood Pressure Disorders Drug Market Share by Application (2015-2020)
Table 64. India Key Players Blood Pressure Disorders Drug Revenue (2019-2020) (Million US$)
Table 65. India Key Players Blood Pressure Disorders Drug Market Share (2019-2020)
Table 66. India Blood Pressure Disorders Drug Market Size by Type (2015-2020) (Million US$)
Table 67. India Blood Pressure Disorders Drug Market Share by Type (2015-2020)
Table 68. India Blood Pressure Disorders Drug Market Size by Application (2015-2020) (Million US$)
Table 69. India Blood Pressure Disorders Drug Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Blood Pressure Disorders Drug Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Blood Pressure Disorders Drug Market Share (2019-2020)
Table 72. Central & South America Blood Pressure Disorders Drug Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Blood Pressure Disorders Drug Market Share by Type (2015-2020)
Table 74. Central & South America Blood Pressure Disorders Drug Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Blood Pressure Disorders Drug Market Share by Application (2015-2020)
Table 76. A1M Pharma AB Company Details
Table 77. A1M Pharma AB Business Overview
Table 78. A1M Pharma AB Product
Table 79. A1M Pharma AB Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 80. A1M Pharma AB Recent Development
Table 81. Acceleron Pharma Inc Company Details
Table 82. Acceleron Pharma Inc Business Overview
Table 83. Acceleron Pharma Inc Product
Table 84. Acceleron Pharma Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 85. Acceleron Pharma Inc Recent Development
Table 86. Ache Laboratorios Farmaceuticos SA Company Details
Table 87. Ache Laboratorios Farmaceuticos SA Business Overview
Table 88. Ache Laboratorios Farmaceuticos SA Product
Table 89. Ache Laboratorios Farmaceuticos SA Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 90. Ache Laboratorios Farmaceuticos SA Recent Development
Table 91. Actelion Pharmaceuticals Ltd Company Details
Table 92. Actelion Pharmaceuticals Ltd Business Overview
Table 93. Actelion Pharmaceuticals Ltd Product
Table 94. Actelion Pharmaceuticals Ltd Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 95. Actelion Pharmaceuticals Ltd Recent Development
Table 96. Aerogen Ltd Company Details
Table 97. Aerogen Ltd Business Overview
Table 98. Aerogen Ltd Product
Table 99. Aerogen Ltd Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 100. Aerogen Ltd Recent Development
Table 101. Anavex Life Sciences Corp Company Details
Table 102. Anavex Life Sciences Corp Business Overview
Table 103. Anavex Life Sciences Corp Product
Table 104. Anavex Life Sciences Corp Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 105. Anavex Life Sciences Corp Recent Development
Table 106. AnGes Inc Company Details
Table 107. AnGes Inc Business Overview
Table 108. AnGes Inc Product
Table 109. AnGes Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 110. AnGes Inc Recent Development
Table 111. Arena Pharmaceuticals Inc Business Overview
Table 112. Arena Pharmaceuticals Inc Product
Table 113. Arena Pharmaceuticals Inc Company Details
Table 114. Arena Pharmaceuticals Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 115. Arena Pharmaceuticals Inc Recent Development
Table 116. Ascendia Pharmaceuticals LLC Company Details
Table 117. Ascendia Pharmaceuticals LLC Business Overview
Table 118. Ascendia Pharmaceuticals LLC Product
Table 119. Ascendia Pharmaceuticals LLC Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 120. Ascendia Pharmaceuticals LLC Recent Development
Table 121. Ascendis Pharma A/S Company Details
Table 122. Ascendis Pharma A/S Business Overview
Table 123. Ascendis Pharma A/S Product
Table 124. Ascendis Pharma A/S Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 125. Ascendis Pharma A/S Recent Development
Table 126. AVEO Pharmaceuticals Inc Company Details
Table 127. AVEO Pharmaceuticals Inc Business Overview
Table 128. AVEO Pharmaceuticals Inc Product
Table 129. AVEO Pharmaceuticals Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 130. AVEO Pharmaceuticals Inc Recent Development
Table 131. Bayer AG Company Details
Table 132. Bayer AG Business Overview
Table 133. Bayer AG Product
Table 134. Bayer AG Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 135. Bayer AG Recent Development
Table 136. Bial - Portela & Ca SA Company Details
Table 137. Bial - Portela & Ca SA Business Overview
Table 138. Bial - Portela & Ca SA Product
Table 139. Bial - Portela & Ca SA Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 140. Bial - Portela & Ca SA Recent Development
Table 141. Bioblue Technologies Inc Company Details
Table 142. Bioblue Technologies Inc Business Overview
Table 143. Bioblue Technologies Inc Product
Table 144. Bioblue Technologies Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 145. Bioblue Technologies Inc Recent Development
Table 146. Biogen Inc Company Details
Table 147. Biogen Inc Business Overview
Table 148. Biogen Inc Product
Table 149. Biogen Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 150. Biogen Inc Recent Development
Table 151. Biolab Farmaceutica Ltda Company Details
Table 152. Biolab Farmaceutica Ltda Business Overview
Table 153. Biolab Farmaceutica Ltda Product
Table 154. Biolab Farmaceutica Ltda Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 155. Biolab Farmaceutica Ltda Recent Development
Table 156. BioRestorative Therapies Inc Company Details
Table 157. BioRestorative Therapies Inc Business Overview
Table 158. BioRestorative Therapies Inc Product
Table 159. BioRestorative Therapies Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 160. BioRestorative Therapies Inc Recent Development
Table 161. Boryung Pharmaceutical Co Ltd Company Details
Table 162. Boryung Pharmaceutical Co Ltd Business Overview
Table 163. Boryung Pharmaceutical Co Ltd Product
Table 164. Boryung Pharmaceutical Co Ltd Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 165. Boryung Pharmaceutical Co Ltd Recent Development
Table 166. Bristol-Myers Squibb Co Company Details
Table 167. Bristol-Myers Squibb Co Business Overview
Table 168. Bristol-Myers Squibb Co Product
Table 169. Bristol-Myers Squibb Co Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 170. Bristol-Myers Squibb Co Recent Development
Table 171. Camurus AB Company Details
Table 172. Camurus AB Business Overview
Table 173. Camurus AB Product
Table 174. Camurus AB Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 175. Camurus AB Recent Development
Table 176. Capricor Therapeutics Inc Company Details
Table 177. Capricor Therapeutics Inc Business Overview
Table 178. Capricor Therapeutics Inc Product
Table 179. Capricor Therapeutics Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 180. Capricor Therapeutics Inc Recent Development
Table 181. Celsion Corp Company Details
Table 182. Celsion Corp Business Overview
Table 183. Celsion Corp Product
Table 184. Celsion Corp Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 185. Celsion Corp Recent Development
Table 186. Celtaxsys Inc Company Details
Table 187. Celtaxsys Inc Business Overview
Table 188. Celtaxsys Inc Product
Table 189. Celtaxsys Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 190. Celtaxsys Inc Recent Development
Table 191. Chiesi Farmaceutici SpA Company Details
Table 192. Chiesi Farmaceutici SpA Business Overview
Table 193. Chiesi Farmaceutici SpA Product
Table 194. Chiesi Farmaceutici SpA Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 195. Chiesi Farmaceutici SpA Recent Development
Table 196. Chong Kun Dang Pharmaceutical Corp Company Details
Table 197. Chong Kun Dang Pharmaceutical Corp Business Overview
Table 198. Chong Kun Dang Pharmaceutical Corp Product
Table 199. Chong Kun Dang Pharmaceutical Corp Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 200. Chong Kun Dang Pharmaceutical Corp Recent Development
Table 201. Chugai Pharmaceutical Co Ltd Company Details
Table 202. Chugai Pharmaceutical Co Ltd Business Overview
Table 203. Chugai Pharmaceutical Co Ltd Product
Table 204. Chugai Pharmaceutical Co Ltd Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 205. Chugai Pharmaceutical Co Ltd Recent Development
Table 206. CJ HealthCare Corp Company Details
Table 207. CJ HealthCare Corp Business Overview
Table 208. CJ HealthCare Corp Product
Table 209. CJ HealthCare Corp Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 210. CJ HealthCare Corp Recent Development
Table 211. Complexa Inc Company Details
Table 212. Complexa Inc Business Overview
Table 213. Complexa Inc Product
Table 214. Complexa Inc Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 215. Complexa Inc Recent Development
Table 216. Corion Biotech Srl Company Details
Table 217. Corion Biotech Srl Business Overview
Table 218. Corion Biotech Srl Product
Table 219. Corion Biotech Srl Revenue in Blood Pressure Disorders Drug Business (2015-2020) (Million US$)
Table 220. Corion Biotech Srl Recent Development
Table 221. Research Programs/Design for This Report
Table 222. Key Data Information from Secondary Sources
Table 223. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Blood Pressure Disorders Drug Market Share by Type: 2020 VS 2026
Figure 2. Diuretics Features
Figure 3. Angiotensin Converting Enzyme (ACE) Inhibitors Features
Figure 4. Angiotensin Receptor Blockers (ARBs) Features
Figure 5. Others Features
Figure 6. Global Blood Pressure Disorders Drug Market Share by Application: 2020 VS 2026
Figure 7. Hypertension Case Studies
Figure 8. Hypotension Case Studies
Figure 9. Pulmonary Hypertension Case Studies
Figure 10. Blood Pressure Disorders Drug Report Years Considered
Figure 11. Global Blood Pressure Disorders Drug Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Blood Pressure Disorders Drug Market Share by Regions: 2020 VS 2026
Figure 13. Global Blood Pressure Disorders Drug Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Blood Pressure Disorders Drug Market Share by Players in 2019
Figure 16. Global Top Blood Pressure Disorders Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Blood Pressure Disorders Drug as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Blood Pressure Disorders Drug Revenue in 2019
Figure 18. North America Blood Pressure Disorders Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Blood Pressure Disorders Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Blood Pressure Disorders Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Blood Pressure Disorders Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Blood Pressure Disorders Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Blood Pressure Disorders Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Blood Pressure Disorders Drug Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. A1M Pharma AB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. A1M Pharma AB Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 27. Acceleron Pharma Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Acceleron Pharma Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 29. Ache Laboratorios Farmaceuticos SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Ache Laboratorios Farmaceuticos SA Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 31. Actelion Pharmaceuticals Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Actelion Pharmaceuticals Ltd Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 33. Aerogen Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Aerogen Ltd Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 35. Anavex Life Sciences Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Anavex Life Sciences Corp Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 37. AnGes Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. AnGes Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 39. Arena Pharmaceuticals Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Arena Pharmaceuticals Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 41. Ascendia Pharmaceuticals LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Ascendia Pharmaceuticals LLC Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 43. Ascendis Pharma A/S Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Ascendis Pharma A/S Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 45. AVEO Pharmaceuticals Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. AVEO Pharmaceuticals Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 47. Bayer AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 48. Bayer AG Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 49. Bial - Portela & Ca SA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Bial - Portela & Ca SA Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 51. Bioblue Technologies Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Bioblue Technologies Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 53. Biogen Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Biogen Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 55. Biolab Farmaceutica Ltda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Biolab Farmaceutica Ltda Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 57. BioRestorative Therapies Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. BioRestorative Therapies Inc Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 59. Boryung Pharmaceutical Co Ltd Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Boryung Pharmaceutical Co Ltd Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 61. Bristol-Myers Squibb Co Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Bristol-Myers Squibb Co Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 63. Camurus AB Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Camurus AB Revenue Growth Rate in Blood Pressure Disorders Drug Business (2015-2020)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Keyplayers in Global Blood Pressure Disorders Drug Market Size, Status and Forecast 2020-2026
A1M Pharma ABAcceleron Pharma Inc
Ache Laboratorios Farmaceuticos SA
Actelion Pharmaceuticals Ltd
Aerogen Ltd
Anavex Life Sciences Corp
AnGes Inc
Arena Pharmaceuticals Inc
Ascendia Pharmaceuticals LLC
Ascendis Pharma A/S
AVEO Pharmaceuticals Inc
Bayer AG
Bial - Portela & Ca SA
Bioblue Technologies Inc
Biogen Inc
Biolab Farmaceutica Ltda
BioRestorative Therapies Inc
Boryung Pharmaceutical Co Ltd
Bristol-Myers Squibb Co
Camurus AB
Capricor Therapeutics Inc
Celsion Corp
Celtaxsys Inc
Chiesi Farmaceutici SpA
Chong Kun Dang Pharmaceutical Corp
Chugai Pharmaceutical Co Ltd
CJ HealthCare Corp
Complexa Inc
Corion Biotech Srl